These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19170075)

  • 1. Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts.
    Mizutani K; Sud S; Pienta KJ
    J Cell Biochem; 2009 Mar; 106(4):563-9. PubMed ID: 19170075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
    Lu Y; Cai Z; Xiao G; Keller ET; Mizokami A; Yao Z; Roodman GD; Zhang J
    Cancer Res; 2007 Apr; 67(8):3646-53. PubMed ID: 17440076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
    Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.
    Araujo JC; Poblenz A; Corn P; Parikh NU; Starbuck MW; Thompson JT; Lee F; Logothetis CJ; Darnay BG
    Cancer Biol Ther; 2009 Nov; 8(22):2153-9. PubMed ID: 19855158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammation and osteoclasts].
    Yokota K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(5):367-376. PubMed ID: 29238019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD; Smith R; Wass JA; Athanasou NA
    Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.
    Yokota K; Sato K; Miyazaki T; Aizaki Y; Tanaka S; Sekikawa M; Kozu N; Kadono Y; Oda H; Mimura T
    Arthritis Rheumatol; 2021 Jul; 73(7):1145-1154. PubMed ID: 33512089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
    Sprangers S; Schoenmaker T; Cao Y; Everts V; de Vries TJ
    J Cell Physiol; 2016 Jun; 231(6):1249-60. PubMed ID: 26491867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.
    Zhang H; Huang Y; Wang S; Fu R; Guo C; Wang H; Zhao J; Gaskin F; Chen J; Yang N; Fu SM
    J Autoimmun; 2015 Dec; 65():82-9. PubMed ID: 26318644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of osteoclastic activity in prostate cancer skeletal metastases.
    Keller ET
    Drugs Today (Barc); 2002 Feb; 38(2):91-102. PubMed ID: 12532187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.
    Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW
    Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
    Hirayama T; Danks L; Sabokbar A; Athanasou NA
    Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.
    Cafiero C; Gigante M; Brunetti G; Simone S; Chaoul N; Oranger A; Ranieri E; Colucci S; Pertosa GB; Grano M; Gesualdo L
    Nephrol Dial Transplant; 2018 Jan; 33(1):65-75. PubMed ID: 28992140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo.
    Yokota K; Sato K; Miyazaki T; Kitaura H; Kayama H; Miyoshi F; Araki Y; Akiyama Y; Takeda K; Mimura T
    Arthritis Rheumatol; 2014 Jan; 66(1):121-9. PubMed ID: 24431283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.
    Bendre MS; Montague DC; Peery T; Akel NS; Gaddy D; Suva LJ
    Bone; 2003 Jul; 33(1):28-37. PubMed ID: 12919697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
    Hwang YS; Lee SK; Park KK; Chung WY
    Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.